1
|
do Nascimento MLLB, Dos Reis AC, Santos JVO, Negreiros HA, da Silva FCC, Ferreira PMP, Gonçalves JCR, Dittz D, Braz DC, Nunes AMV, Cunha RLOR, Melo-Cavalcante AAC, de Castro E Sousa JM. Antiproliferative and Genotoxic Action of an Underexploited Organoteluran Derivative on Sarcoma 180 Cells. Anticancer Agents Med Chem 2021; 21:1019-1026. [PMID: 32951579 DOI: 10.2174/1871520620666200918110152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 07/31/2020] [Accepted: 08/08/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND The search for novel metallic chemical compounds with toxicogenic effects has been of great importance for more efficient cancer treatment. OBJECTIVE The study evaluated the cytotoxic, genotoxic and mutagenic activity of organoteluran RF07 in the S-180 cell line. METHODS The bioassays used were cell viability with 3-(4,5-dimethyl-2-thiazole)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) test, evaluation of apoptosis and necrosis using fluorescence and flow cytometry, cytokinesisblock micronucleus test and comet assay. The compound was tested at 1; 2.5 and 5μM. RESULTS The results showed the cytotoxicity of RF07 at concentrations of 2.5, 5, 10 and 20μM when compared to the negative control. For genotoxicity tests, RF07 showed effects in all concentrations assessed by increased index and frequencies of damage and mutagenic alterations. The compound was also cytotoxic due to the significant decrease in the nuclear division index, with significant values of apoptosis and necrosis. The results of fluorescence and flow cytometry showed apoptosis as the main type of cell death caused by RF07 at 5μM, which is thought to avoid an aggressive immune response of the organism. CONCLUSION In addition to cytotoxic and genotoxic effects, RF07 creates good perspectives for future antitumor formulations.
Collapse
Affiliation(s)
- Maria L L Barreto do Nascimento
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | - Antonielly Campinho Dos Reis
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | - José V O Santos
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | - Helber A Negreiros
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | | | - Paulo M P Ferreira
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | - Juan C R Gonçalves
- Department of Pharmaceutical Sciences, Federal University of Paraiba, Joao Pessoa, Brazil
| | - Dalton Dittz
- Department of Biochemistry and Pharmacology, Federal University of Piaui, Teresina, Brazil
| | - Débora C Braz
- Department of Pharmacy, University of Piaui, Teresina, Brazil
| | - Adriana M V Nunes
- Department of Biophysics and Physiology, Laboratory of Experimental Cancerology, Federal University of Piaui, Teresina, Brazil
| | - Rodrigo L O R Cunha
- Center for Natural and Human Sciences, Laboratory of Chemical Biology, Federal University of ABC, Santo Andre, Brazil
| | - Ana A C Melo-Cavalcante
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| | - João Marcelo de Castro E Sousa
- Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina, Brazil
| |
Collapse
|